Eden Research (LON:EDEN) Shares Down 4.7% – Here’s Why

Eden Research plc (LON:EDEN) shares were down 4.7% during trading on Friday . The stock traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.43 ($0.04). Approximately 291,737 shares traded hands during trading, a decline of 69% from the average daily volume of 928,598 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Trading Down 3.3 %

The company’s 50 day moving average price is GBX 3.87 and its 200 day moving average price is GBX 3.95. The company has a market cap of £18.56 million, a price-to-earnings ratio of -12.19 and a beta of 0.92. The company has a debt-to-equity ratio of 1.26, a quick ratio of 2.42 and a current ratio of 3.80.

Insider Activity at Eden Research

In other Eden Research news, insider Alexander John Abrey acquired 540,540 shares of Eden Research stock in a transaction dated Tuesday, January 28th. The stock was bought at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,317.25). Also, insider Lykele van der Broek acquired 256,000 shares of Eden Research stock in a transaction dated Thursday, February 6th. The shares were acquired at an average cost of GBX 4 ($0.05) per share, with a total value of £10,240 ($12,937.46). 14.02% of the stock is currently owned by company insiders.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.